Skip to main content

J&J To Pay $3.9M To Settle WV Mesh Lawsuit

J&J To Pay $3.9M To Settle WV Mesh Lawsuit

J&J To Pay $3.9M To Settle WV Mesh Lawsuit

Introduction

On Monday, West Virginia state Attorney General Patrick Morrisey announced that the state reached a $3.9 million settlement with Johnson & Johnson (J&J) and its subsidiaries over the lawsuit involving its surgical mesh used to treat pelvic conditions in women.

A consumer protection case was filed against J&J in September, alleging that the company communicated misleading information about the risks and effectiveness of the mesh by using studies written by paid consultants.

The settlement will also solve the allegations against J&J that deceptive marketing practices were used over metal-on-metal hip replacement systems.

The pelvic mesh was approved, for surgical usage, by the FDA in 2002. Later, in April 2019, sales of the synthetic mesh were stopped after receiving many injury reports as well as tens of thousands of lawsuits from women claiming they had bleeding, severe pain, and infection from the products.

In January, J&J paid nearly $344 million in penalties over the marketing of the pelvic mesh devices in a lawsuit brought by California. The company also agreed to pay $117million settlement in October, involving similar allegations with 41 other states and the District of Columbia.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!